Aligos Therapeutics

ALGS

Börsenwert 12,4 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Armistice Capital New York	4,54 Mio. $	+4,7 Mio. $	+273.355	Neu
2	2 EcoR1 Capital San Francisco, California	4,24 Mio. $	+1,68 Mio. $	+97.645	+62 %
3	3 Deep Track Capital Greenwich, Connecticut	4,05 Mio. $	+4,2 Mio. $	+244.111	Neu
4	4 Vivo Capital Palo Alto, California	2,36 Mio. $	–	–	–
5	5 Alyeska Investment Group Chicago, Illinois	1,91 Mio. $	+1,98 Mio. $	+115.289	Neu
6	ACP 6 Altitude Crest Partners Stamford, Connecticut	1,89 Mio. $	+1,96 Mio. $	+113.787	Neu
7	7 Versant Venture Management San Francisco, California	1,54 Mio. $	–	–	–
8	8 Tang Capital Management San Diego, California	1,45 Mio. $	-783.451 $	-45.568	-34 %
9	BBA 9 Baker Bros. Advisors New York	1,38 Mio. $	–	–	–
10	10 HHLR Advisors Grand Cayman, Cayman Islands	1,27 Mio. $	-277.547 $	-16.143	-17 %
11	OM 11 Opaleye Management Boston, Massachusetts	861.208 $	+891.973 $	+51.880	Neu
12	NM 12 Newtyn Management New York	833.320 $	+230.386 $	+13.400	+36 %
13	13 Bank of America Charlotte, North Carolina	762.114 $	-1.702 $	-99	-0,2 %
14	14 Vanguard Group Malvern, Pennsylvania	671.736 $	+705 $	+41	+0,1 %
15	15 Pivotal bioVenture Partners Investment Advisor San Francisco, California	493.495 $	–	–	–
16	16 Silverarc Capital Management Boston, Massachusetts	443.892 $	+25.188 $	+1.465	+6 %
17	17 Acadian Asset Management Boston, Massachusetts	370.000 $	-3.679 $	-214	-0,9 %
18	18 Renaissance Technologies New York	325.000 $	+115.950 $	+6.744	+52 %
19	19 Geode Capital Management Boston, Massachusetts	213.222 $	+54.708 $	+3.182	+33 %
20	20 BlackRock New York	196.636 $	-550 $	-32	-0,3 %
21	21 State Street Boston, Massachusetts	64.689 $	–	–	–
22	22 Bridgeway Capital Management Houston, Texas	61.088 $	–	–	–
23	23 Northern Trust Chicago, Illinois	35.835 $	+10.058 $	+585	+37 %
24	24 Charles Schwab San Francisco, California	20.838 $	–	–	–
25	25 Millennium Management New York	19.060 $	-43.395 $	-2.524	-69 %

Aligos Therapeutics ALGS Börsenwert 12,4 Mio. $

Aligos Therapeutics

ALGS

Börsenwert 12,4 Mio. $